|
|
Volumn 2, Issue 5, 2000, Pages 409-416
|
|
Intermittent androgen deprivation.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIANDROGEN;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
PROSTATE SPECIFIC ANTIGEN;
ANIMAL;
APOPTOSIS;
CLINICAL TRIAL;
DISEASE COURSE;
DISEASE MODEL;
DRUG ADMINISTRATION;
HUMAN;
MALE;
MOUSE;
NUDE MOUSE;
PROSTATE TUMOR;
QUALITY OF LIFE;
REVIEW;
SEXUALITY;
ANDROGEN ANTAGONISTS;
ANIMALS;
ANTINEOPLASTIC AGENTS, HORMONAL;
APOPTOSIS;
CLINICAL TRIALS;
DISEASE MODELS, ANIMAL;
DISEASE PROGRESSION;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
MALE;
MICE;
MICE, NUDE;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
QUALITY OF LIFE;
SEXUALITY;
|
|
EID: 0034276674
PISSN: 15233790
EISSN: None
Source Type: Journal
DOI: 10.1007/s11912-000-0060-6 Document Type: Review |
|
Times cited : (12)
|
|
References (49)
|
